Business Context and Reporting Period
Company: American Shared Hospital Services (ASHS)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2025
Business Overview: ASHS provides turn-key technology solutions for stereotactic radiosurgery and advanced radiation therapy. Operations are divided into two reportable segments: Leasing (medical equipment leasing to hospitals) and Direct Patient Services (stand-alone facilities in Rhode Island, Peru, Ecuador, and Mexico). The company is a non-accelerated filer and smaller reporting company.
Key Financial Metrics (Six Months Ended June 30, 2025)
| Metric | 2025 (6 Months) | 2024 (6 Months) |
|---|---|---|
| Total Revenue | $13,183,000 | $12,272,000 |
| Gross Margin | $2,572,000 (19.5%) | $4,611,000 (37.6%) |
| Operating Loss | $(1,843,000) | $(86,000) |
| Net Loss | $(1,390,000) | $3,833,000 |
| Net Loss Attributable to ASHS | $(905,000) | $3,721,000 |
| Diluted EPS | $(0.14) | $0.57 |
| Cash and Cash Equivalents | $11,081,000 | $14,236,000 |
| Total Debt (Current + Long-Term) | $19,094,000 | $20,182,000 |
| Working Capital | $3,573,000 | $15,853,000 |
Material Changes vs. Prior Period
- Revenue Mix Shift: Total revenue increased 7.4% year-over-year, driven by a 60.7% increase in Direct Patient Services revenue ($6.62M vs $4.12M) due to the Rhode Island (RI) Acquisition and the new Puebla, Mexico facility. Conversely, Leasing revenue declined 19.5% ($6.56M vs $8.15M) due to lower Gamma Knife volumes from expiring contracts and reduced Proton Beam Radiation Therapy (PBRT) usage.
- Profitability Decline: The company reported a net loss of $905,000 attributable to shareholders, compared to net income of $3.72M in the prior year. This reversal is primarily due to the absence of a $3.68M bargain purchase gain recorded in 2024 from the RI Acquisition, combined with lower operating volumes and increased depreciation from new assets.
- Cost Structure: Costs of revenue increased 38.5% to $10.61M, driven by operating costs from the newly acquired RI facilities and the Puebla facility, as well as higher maintenance costs for Gamma Knife units no longer under warranty.
- Liquidity Position: Working capital decreased significantly by $12.28M to $3.57M, primarily due to a $5.0M draw on the revolving line of credit and an increase in the current portion of long-term debt.
Outlook, Risks, and Unusual Items
- Debt Covenant Compliance: The company was not in compliance with the maximum funded debt to EBITDA ratio covenant under its Credit Agreement as of June 30, 2025. However, management stated it regained compliance on July 1, 2025.
- Capital Commitments: ASHS has $8.39M in commitments to purchase and install three Gamma Knife Esprit systems and two LINAC systems, with installations scheduled for late 2025 or later. Additionally, there are $11.93M in service commitments.
- Internal Controls: The company disclosed that disclosure controls and procedures were not effective as of June 30, 2025, due to a material weakness regarding insufficient personnel and resources with experience in financial reporting. Remediation includes hiring a new CFO and additional accounting staff.
- Subsequent Event: On July 4, 2025, the "One Big Beautiful Bill Act" was signed into law. The company is evaluating the impact of new tax provisions (e.g., 100% bonus depreciation) and will reflect adjustments in the third quarter of 2025.
- Volume Risks: Gamma Knife procedure volumes decreased 19% in the leasing segment due to contract expirations. International volumes in Peru and Ecuador were impacted by local government payor contract delays.
Investor Verification Checklist
- Covenant Status: Verify the company's sustained compliance with the funded debt to EBITDA ratio following the July 1, 2025 date.
- Capital Expenditure Funding: Assess the availability of financing for the $8.39M in equipment commitments given the current debt load and working capital reduction.
- Internal Control Remediation: Monitor progress on hiring experienced accounting personnel and bringing billing cycles in-house to address the material weakness in internal controls.
- Volume Recovery: Track procedure volumes for the leasing segment to determine if the decline from expiring contracts is temporary or structural.
- Tax Impact: Review Q3 2025 filings for the financial impact of the new tax legislation enacted in July 2025.